Waypoint Wealth Counsel Eli Lilly & CO Transaction History
Waypoint Wealth Counsel
- $149 Billion
- Q3 2024
A detailed history of Waypoint Wealth Counsel transactions in Eli Lilly & CO stock. As of the latest transaction made, Waypoint Wealth Counsel holds 648 shares of LLY stock, worth $522,378. This represents 0.39% of its overall portfolio holdings.
Number of Shares
648
Previous 541
19.78%
Holding current value
$522,378
Previous $490 Million
17.21%
% of portfolio
0.39%
Previous 0.37%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
3,913Shares Held
765MCall Options Held
6.34MPut Options Held
7.96M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$78.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$59.5 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.1 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.4 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.3 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $766B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...